Soleno Therapeutics's total assets for Q1 2025 were $318.09M, a decrease of -3.89% from the previous quarter. SLNO total liabilities were $85.83M for the fiscal quarter, a -0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.